Intact mass and middle-down analysis for mAbs
Ontology highlight
ABSTRACT: An integrated strategy has been developed to characterize Trastuzumab and Adalimumab structural heterogeneity, which has prominent advantages in fast sample preparation with minimal artifacts, and complementary information obtained from intact mass and middle-down analyses.
ORGANISM(S): Homo Sapiens
SUBMITTER: Jinlan Zhang
PROVIDER: PXD021287 | iProX | Thu Sep 03 00:00:00 BST 2020
REPOSITORIES: iProX
ACCESS DATA